Tax evaders may face asset seizures

Tax evaders may face asset seizures

Evading taxes worth 10 million baht or more, or fraudulently filing for tax refunds of 2 million baht or more through collusion, shall be considered a money-laundering offence, according to a new law taking effect on Sunday.

The amendment to the Revenue Code published in the Royal Gazette on Saturday added a provision on tax penalties.

In essence, it classifies evading taxes of 10 million baht or more per tax year, or fraudulently filing for tax refunds of 2 million baht or more through collusion, as a money-laundering offence.

"Once the Revenue Department, with the approval of the tax offence screening committee, sends the information of such a case to the Anti-Money Laundering Office, action can be taken under the Anti-Money Laundering Act."

Such action includes immediately seizing the assets of the offenders for 90 days if there is "probable cause" that they might be moved or transferred.

The screening committee comprises the Revenue Department director-general, his deputies and revenue advisers.

The law cited as a reason for the change compliance with the terms of references of the Asia Pacific Group on Money Laundering (APG).

"As a founding member of the APG, Thailand needs to comply with the terms of references, which require member countries conform to the guidelines of the Finance Action Task Force (FATF)."

The law also aims to enhance efficiency in suppressing tax evasion and fraud.


Do you like the content of this article?
COMMENT (6)

Here to stay

Gen Prayut Chan-o-cha says he will serve his full term as prime minister, ending speculation he may dissolve the House and call a fresh election before his term ends in 2023.

14 Jun 2021

Man with 39 wives dies in India

NEW DELHI: A 76-year-old man who had 39 wives and 94 children and was said to be the head of the world's largest family has died in northeast India, the chief minister of his home state said.

14 Jun 2021

Novavax vaccine more than 90% effective in US trial

Novavax Inc on Monday reported late-stage data from its US-based clinical trial showing its vaccine is more than 90% effective against Covid-19 across a variety of variants of the virus.

14 Jun 2021